Nadia Benchakroun Selected Research

Nadia Benchakroun Research Topics

7	Neoplasms (Cancer) 01/2022 - 02/2011
2	Lung Neoplasms (Lung Cancer) 01/2022 - 10/2019
1	Nasopharyngeal Carcinoma 02/2021
1	Neoplasm Metastasis (Metastasis) 02/2021
1	Cardiotoxicity 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Inflammation (Inflammations) 10/2019
1	Phyllodes Tumor (Cystosarcoma Phylloides) 01/2016
1	Aggressive Fibromatosis (Desmoid) 12/2014
1	Papillomavirus Infections 02/2011

2	CytokinesIBA 01/2022 - 10/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 10/2019
2	DNA (Deoxyribonucleic Acid)IBA 02/2021 - 02/2011
2	Tyrosine Kinase InhibitorsIBA 12/2014 - 01/2012
2	Imatinib Mesylate (Gleevec)FDA Link 12/2014 - 01/2012
1	Messenger RNA (mRNA)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	InterleukinsIBA 01/2022
1	Macrophage Migration-Inhibitory FactorsIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 02/2021
1	Trastuzumab (Herceptin)FDA Link 01/2021
1	AnthracyclinesIBA 01/2021
1	VimentinIBA 01/2017
1	Inhibins (Inhibin)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 02/2011
1	OligonucleotidesIBA 02/2011

4	Radiotherapy 01/2021 - 12/2014
1	Therapeutics 01/2021